Amide Technologies

About Amide Technologies

Amide Technologies focuses on on-demand polyamide manufacturing at unprecedented speed, bridging the synthesis gap in peptide production. They aim to accelerate drug discovery by synthesizing hard-to-obtain peptides using unnatural amino acids and artificial protein backbones, expanding biological possibilities.

Products & Services

Peptide Synthesis:Offers high-speed delivery of peptides, including complex and long polyamides up to 120 amino acids, with a minimum turnaround time of 4 days and over 99% on-time delivery rate.

Complex Compound Access:Provides access to large and unusual compounds like mirror image proteins and branched structures, enabling novel therapeutic modalities for drug development.

Specialties

Peptide Synthesis Drug Discovery Complex Polyamide Manufacturing Therapeutic Modalities

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A Extension T: - FT: Series A Extension	A: 16500000 MR: - FA: $16.5 million FAN: 16500000	D: 2023-12-14 FD: 2023-12-14	3 investors

Series A Extension Latest

2023-12-14

$16.5M

3 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

B

Brad Pentelute

CEO, Board Member

P

Phil Dixon

COO

J

Jeremy Wertheimer

Board Chair - CEO, Biological Engineering Ventures

R

Reed Sturtevant

Board Member

N

Nessan Bermingham

Board Member

A

Alex Martinez

Research Associate, Protein Purification

View 14 more team members with Pro

Unlock Full Team Directory

Recent News